ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant, Medical

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,153Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 66

$348K Total Retail Price of All Prescriptions

Rank: 2 out of 66

655 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 655 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

10% of this provider’s 655 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 7,002 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 527 432 1 1
AMLODIPINE BESYLATE 457 391 2 8
SIMVASTATIN 420 358 3 4
LEVOTHYROXINE SODIUM 418 351 4 3
OMEPRAZOLE 337 228 5 5
METFORMIN HCL 336 281 6 6
HYDROCODONE-ACETAMINOPHEN 285 190 S3 7 2
AZITHROMYCIN 229 160 8 21
GLYBURIDE 156 139 R 9 66
PREDNISONE 155 108 10 40
RANITIDINE HCL 143 99 11 18
ATENOLOL 143 129 11 34
CRESTOR 140 95 13 36
ZOLPIDEM TARTRATE 139 111 14 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 127 15 17
GABAPENTIN 138 104 15 9
LOSARTAN POTASSIUM 125 116 17 26
CEFUROXIME 117 92 18 78
HYDROCHLOROTHIAZIDE 116 96 19 10
PROAIR HFA 114 86 20 33
LOSARTAN-HYDROCHLOROTHIAZIDE 112 96 21 61
METOPROLOL SUCCINATE 102 70 22 14
FUROSEMIDE 94 78 23 15
IBUPROFEN 89 67 24 27
METOPROLOL TARTRATE 85 81 25 13
FLUOXETINE HCL 84 54 26 64
LOVASTATIN 81 65 27 16
CITALOPRAM HBR 78 51 28 54
ENDOCET 77 47 S2 29 52
NAMENDA 73 73 30 96
TRAZODONE HCL 73 38 30 70
CIPROFLOXACIN HCL 68 59 32 39
POTASSIUM CHLORIDE 67 54 33 46
GLIPIZIDE 67 62 33 29
OXYBUTYNIN CHLORIDE 62 53 35 76
OXYCODONE HCL 62 32 S2 35 7
LANTUS 56 55 37 43
ADVAIR DISKUS 56 44 37 57
ALLOPURINOL 56 45 37 55
ONDANSETRON HCL 55 47 40 81
ALENDRONATE SODIUM 54 53 41 24
OXYCONTIN 53 20 S2 42 35
FLUCONAZOLE 53 40 42 80
CARBIDOPA-LEVODOPA 52 49 44 109
ATORVASTATIN CALCIUM 52 51 44 23
DONEPEZIL HCL 51 47 46 112
DOXYCYCLINE HYCLATE 51 30 46 112
PROMETHAZINE HCL 50 0 R 48 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.